Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production

We have investigated whether the vessel wall may release or synthetize some substance able to modify the platelet function independent of prostacyclin (PGI2) production. Twenty female rats were injected with indomethacin. 18 hours after the injection animals were sacrified and rings cut from thoraci...

Descripción completa

Detalles Bibliográficos
Autores principales: Schattner, M.A., Gimeno, M., Lazzari, M.A.
Formato: JOUR
Materias:
rat
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_02621746_v19_n3_p251_Schattner
Aporte de:
id todo:paper_02621746_v19_n3_p251_Schattner
record_format dspace
spelling todo:paper_02621746_v19_n3_p251_Schattner2023-10-03T15:12:36Z Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production Schattner, M.A. Gimeno, M. Lazzari, M.A. adenosine diphosphate adrenalin arachidonic acid collagen icosatetraynoic acid mepacrine nordihydroguaiaretic acid prostacyclin thrombin tranylcypromine animal cell aorta blood and hemopoietic system blood vessel cardiovascular system drug efficacy great blood vessel inhibition nonhuman priority journal rat thrombocyte aggregation 5,8,11,14-Eicosatetraynoic Acid Animal Aorta Aspirin Catechols Endothelium Female Human In Vitro Indomethacin Nordihydroguaiaretic Acid Platelet Aggregation Rats We have investigated whether the vessel wall may release or synthetize some substance able to modify the platelet function independent of prostacyclin (PGI2) production. Twenty female rats were injected with indomethacin. 18 hours after the injection animals were sacrified and rings cut from thoracic and abdominal aorta were obtained. They were incubated in Krebs solution for different periods of time after which an aliquot from the indomethacin treated rat's aortic ring (ITRAR) was assayed on platelet aggregation induced by several agonists. The supernatant from the 40 min. incubation mixture of ITRAR released a substance which completely inhibits platelet aggregation induced by arachidonic acid (AA), ADP, epinephrine, collagen, ristocetin and thrombin. The time of appearance of the substance varied with a mean of 17 min. It is released with and without AA stimulation. Once generated it is active for at least three hours; its antiaggregating activity remains even if it is boiled for 15 sec, incubated at 37°C, or if the vessel is treated with tranylcypromine. Platelet aggregation inhibition is still evident if the supernatant from ITRAR is transferred to a platelet rich plasma (PRP) from a normal donor who had taken an aspirin 24 hours before sampling. All these results indicate that this substance released from ITRAR is not prostacyclin. Nordihydroguaiaretic or eicosatetraynoic acid which are lipoxygenase inhibitors could not modify the ITRAR's release; nor did mepacrine which is a phospholipase inhibitor. Since mepacrine does not completely inhibit phospholipase activities we cannot exclude the possibility that the substance is derived from AA. More studies are in progress to elucidate the biochemical properties of this substance. © 1985. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_02621746_v19_n3_p251_Schattner
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic adenosine diphosphate
adrenalin
arachidonic acid
collagen
icosatetraynoic acid
mepacrine
nordihydroguaiaretic acid
prostacyclin
thrombin
tranylcypromine
animal cell
aorta
blood and hemopoietic system
blood vessel
cardiovascular system
drug efficacy
great blood vessel
inhibition
nonhuman
priority journal
rat
thrombocyte aggregation
5,8,11,14-Eicosatetraynoic Acid
Animal
Aorta
Aspirin
Catechols
Endothelium
Female
Human
In Vitro
Indomethacin
Nordihydroguaiaretic Acid
Platelet Aggregation
Rats
spellingShingle adenosine diphosphate
adrenalin
arachidonic acid
collagen
icosatetraynoic acid
mepacrine
nordihydroguaiaretic acid
prostacyclin
thrombin
tranylcypromine
animal cell
aorta
blood and hemopoietic system
blood vessel
cardiovascular system
drug efficacy
great blood vessel
inhibition
nonhuman
priority journal
rat
thrombocyte aggregation
5,8,11,14-Eicosatetraynoic Acid
Animal
Aorta
Aspirin
Catechols
Endothelium
Female
Human
In Vitro
Indomethacin
Nordihydroguaiaretic Acid
Platelet Aggregation
Rats
Schattner, M.A.
Gimeno, M.
Lazzari, M.A.
Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
topic_facet adenosine diphosphate
adrenalin
arachidonic acid
collagen
icosatetraynoic acid
mepacrine
nordihydroguaiaretic acid
prostacyclin
thrombin
tranylcypromine
animal cell
aorta
blood and hemopoietic system
blood vessel
cardiovascular system
drug efficacy
great blood vessel
inhibition
nonhuman
priority journal
rat
thrombocyte aggregation
5,8,11,14-Eicosatetraynoic Acid
Animal
Aorta
Aspirin
Catechols
Endothelium
Female
Human
In Vitro
Indomethacin
Nordihydroguaiaretic Acid
Platelet Aggregation
Rats
description We have investigated whether the vessel wall may release or synthetize some substance able to modify the platelet function independent of prostacyclin (PGI2) production. Twenty female rats were injected with indomethacin. 18 hours after the injection animals were sacrified and rings cut from thoracic and abdominal aorta were obtained. They were incubated in Krebs solution for different periods of time after which an aliquot from the indomethacin treated rat's aortic ring (ITRAR) was assayed on platelet aggregation induced by several agonists. The supernatant from the 40 min. incubation mixture of ITRAR released a substance which completely inhibits platelet aggregation induced by arachidonic acid (AA), ADP, epinephrine, collagen, ristocetin and thrombin. The time of appearance of the substance varied with a mean of 17 min. It is released with and without AA stimulation. Once generated it is active for at least three hours; its antiaggregating activity remains even if it is boiled for 15 sec, incubated at 37°C, or if the vessel is treated with tranylcypromine. Platelet aggregation inhibition is still evident if the supernatant from ITRAR is transferred to a platelet rich plasma (PRP) from a normal donor who had taken an aspirin 24 hours before sampling. All these results indicate that this substance released from ITRAR is not prostacyclin. Nordihydroguaiaretic or eicosatetraynoic acid which are lipoxygenase inhibitors could not modify the ITRAR's release; nor did mepacrine which is a phospholipase inhibitor. Since mepacrine does not completely inhibit phospholipase activities we cannot exclude the possibility that the substance is derived from AA. More studies are in progress to elucidate the biochemical properties of this substance. © 1985.
format JOUR
author Schattner, M.A.
Gimeno, M.
Lazzari, M.A.
author_facet Schattner, M.A.
Gimeno, M.
Lazzari, M.A.
author_sort Schattner, M.A.
title Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
title_short Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
title_full Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
title_fullStr Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
title_full_unstemmed Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
title_sort rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production
url http://hdl.handle.net/20.500.12110/paper_02621746_v19_n3_p251_Schattner
work_keys_str_mv AT schattnerma ratsvesselwallgeneratesanantiaggregatorysubstanceindependentofprostacyclinproduction
AT gimenom ratsvesselwallgeneratesanantiaggregatorysubstanceindependentofprostacyclinproduction
AT lazzarima ratsvesselwallgeneratesanantiaggregatorysubstanceindependentofprostacyclinproduction
_version_ 1807316346665435136